The Treatment of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections
- 1 January 2008
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 27 (1) , 67-68
- https://doi.org/10.1097/inf.0b013e31816087a7
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Counterpoint: Vancomycin and Staphylococcus aureus--An Antibiotic Enters ObsolescenceClinical Infectious Diseases, 2007
- Point: Vancomycin Is Not Obsolete for the Treatment of Infection Caused by Methicillin-Resistant Staphylococcus aureusClinical Infectious Diseases, 2007
- Emerging Options for Treatment of Invasive, Multidrug‐Resistant Staphylococcus aureus InfectionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue InfectionsAntimicrobial Agents and Chemotherapy, 2005
- Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureusThe Pediatric Infectious Disease Journal, 2004
- Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonatesThe Pediatric Infectious Disease Journal, 2003
- Linezolid versus vancomycin for treatment of resistant Gram-positive infections in childrenThe Pediatric Infectious Disease Journal, 2003
- Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus InfectionAnnals of Internal Medicine, 1992